HON. RON PAUL
OF TEXAS
IN THE HOUSE OF REPRESENTATIVES
Wednesday, December 12, 2007
2007 Ron Paul 107:1
Mr. PAUL. Madam Speaker, researchers at the University of Texas Medical Branch
(UTMB) have been responsible for two significant
medical breakthroughs that have the potential
to dramatically improve American health
care.
2007 Ron Paul 107:2
Earlier this year, Dr. Lisa Elferink, an associate professor at UTMBs Cancer Center, led
a national research team that discovered how
use of the bacterial pathogen, Listeria
monocytogenes could help medical researchers
and practitioners understand the mechanisms
by which cancer cells develop. This discovery
is a major step in developing successful
treatments for a variety of cancers.
2007 Ron Paul 107:3
Another team of UTMB researchers, lead by Dr. Angela Shepherd, have helped American
men at risk of osteoporosis by developing the
Male Osteoporosis Risk Estimation Score
(MORES). While osteoporosis screening is
common for women, many men who are at
risk for this bone disease are not regularly
checked. MORES provides a quick and easy
way to identify men who may need further
screening and possibly treatment for
osteoporosis.
2007 Ron Paul 107:4
The development of MORES and the new use of Listeria monocytogenes are just two of
the advances in medical research to come out
of UTMB. UTMB is one of Americas leading
centers of medical research, as well as a
source of quality health care for the people of
the Gulf Coast of Texas. Madam Speaker, it
gives me great pleasure to extend my congratulations
to the researchers involved in
these recent breakthroughs and to everyone
associated with UTMB for their tireless work to
improve health care.